Citius Oncology (CTOR) Change in Cash (2023 - 2026)

Citius Oncology's Change in Cash history runs 4 years deep, the most recent figure standing at -$4.7 million for Q1 2026.

• In Q1 2026, Change in Cash changed N/A year-over-year to -$4.7 million; the TTM figure through Mar 2026 stood at -$1.3 million (changed N/A YoY), while the FY2025 annual figure was $3.9 million, up 3504182.14% from the prior year.
• Change in Cash was -$4.7 million for Q1 2026 at Citius Oncology, down from $3.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $3.4 million in Q4 2025 to a low of -$4.7 million in Q1 2026.
• Historically, Change in Cash has averaged -$215213.0 across 4 years, with a median of -$33069.0 in 2024.
• Biggest YoY gain for Change in Cash was 100.35% in 2024; the steepest drop was 113.24% in 2024.
• A 4-year view of Change in Cash shows it stood at -$262652.0 in 2023, then soared by 87.41% to -$33069.0 in 2024, then jumped by 10292.46% to $3.4 million in 2025, then plunged by 238.34% to -$4.7 million in 2026.
• The last three Change in Cash figures came in at -$4.7 million (Q1 2026), $3.4 million (Q4 2025), and -$33069.0 (Q2 2024), per Business Quant data.